BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26831608)

  • 1. Noninvasive fibrosis marker can predict recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Chung HA; Kim JH; Hwang Y; Choi HS; Ko SY; Choe WH; Kwon SY
    Saudi J Gastroenterol; 2016; 22(1):57-63. PubMed ID: 26831608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Tsuchiya K; Komuta M; Yasui Y; Tamaki N; Hosokawa T; Ueda K; Kuzuya T; Itakura J; Nakanishi H; Takahashi Y; Kurosaki M; Asahina Y; Enomoto N; Sakamoto M; Izumi N
    Oncology; 2011; 80(3-4):278-88. PubMed ID: 21734420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
    Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS
    Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FIB-4 index is a significant prognostic factor in patients with non-B non-C hepatocellular carcinoma after curative surgery.
    Okamura Y; Ashida R; Yamamoto Y; Ito T; Sugiura T; Bekku E; Aramaki T; Uesaka K
    Langenbecks Arch Surg; 2016 Mar; 401(2):195-203. PubMed ID: 26943655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topographical impact of hepatitis B-related hepatocellular carcinoma on local recurrence after radiofrequency ablation.
    Kim JS; Kim W; So YH; Yu SJ; Kim BG
    J Clin Gastroenterol; 2014 Jan; 48(1):66-72. PubMed ID: 23751848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
    Lee S; Rhim H; Kim YS; Kang TW; Song KD
    Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.
    Kawamura Y; Ikeda K; Seko Y; Hosaka T; Kobayashi M; Saitoh S; Kumada H
    AJR Am J Roentgenol; 2011 Oct; 197(4):W665-73. PubMed ID: 21940538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation.
    Lee YR; Park SY; Kim SU; Jang SY; Tak WY; Kweon YO; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Hur K
    J Gastroenterol Hepatol; 2017 May; 32(5):1079-1086. PubMed ID: 27859615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspartate aminotransferase-to-platelet ratio index for predicting late recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Zhang X; Xin Y; Yang Y; Chen Y; Cao XJ; Wang Y; Fan Q; Zhou X; Li X
    Int J Hyperthermia; 2022; 39(1):437-445. PubMed ID: 35249443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
    Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
    World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection.
    Choi WM; Lee JH; Ahn H; Cho H; Cho YY; Lee M; Yoo JJ; Cho Y; Lee DH; Lee YB; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS; Kim CY; Lee HS
    Liver Int; 2015 Aug; 35(8):1992-2000. PubMed ID: 25556714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.
    Liu Y; Wang ZX; Cao Y; Zhang G; Chen WB; Jiang CP
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):266-74. PubMed ID: 27298102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.
    Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD; Wu JC
    J Clin Gastroenterol; 2012 Jan; 46(1):62-70. PubMed ID: 21934530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus-related hepatocellular carcinoma after radiofrequency ablation.
    Lee TY; Lin JT; Zeng YS; Chen YJ; Wu MS; Wu CY
    Hepatology; 2016 May; 63(5):1517-27. PubMed ID: 26426978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
    Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
    J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation.
    Facciorusso A; Del Prete V; Antonino M; Crucinio N; Neve V; Di Leo A; Carr BI; Barone M
    Dig Liver Dis; 2014 Nov; 46(11):1014-9. PubMed ID: 25085684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
    Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrence.
    Kono M; Inoue T; Kudo M; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Ueshima K; Nishida N; Murakami T
    Dig Dis; 2014; 32(6):670-7. PubMed ID: 25376283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.
    Ziol M; Sutton A; Calderaro J; Barget N; Aout M; Leroy V; Blanc JF; Sturm N; Bioulac-Sage P; Nahon P; Nault JC; Charnaux N; N'kontchou G; Trinchet JC; Delehedde M; Seror O; Beaugrand M; Vicaut E; Ganne-Carrié N
    J Hepatol; 2013 Dec; 59(6):1264-70. PubMed ID: 23928407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil-to-lymphocyte ratio predicts recurrence after radiofrequency ablation in hepatitis B virus infection.
    Tajiri K; Baba H; Kawai K; Minemura M; Yasumura S; Takahara T; Sugiyama T
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1291-9. PubMed ID: 26729319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.